Skip to main content
. 2022 Aug 2;9(8):1159. doi: 10.3390/children9081159

Figure 2.

Figure 2

Figure 2

Median percent reduction from baseline in monthly drop seizure frequency and ≥50% seizure-responder rates as reported in the randomized controlled trial of fenfluramine in patients with Lennox–Gastaut syndrome [69]. p values with statistical comparison were documented in the text.